Drug‐resistance of <i>Trypanosoma b. rhodesiense</i> isolates from Tanzania

Tropical Medicine and International Health - Tập 11 Số 2 - Trang 144-155 - 2006
S. N. Kibona1,2, Lucas E. Matemba2, Josephat S. Kaboya2, George W. Lubega1
1Faculty of Veterinary Medicine, Makerere University, Kampala, Uganda
2National Institute for Medical Research, Tabora, Tanzania

Tóm tắt

SummaryObjective  To determine the drug resistance of Trypanosoma brucei rhodesiense strains isolated from sleeping sickness patients in Tanzania.Method  We first screened 35 T. b. rhodesiense strains in the mouse model, for sensitivity to melarsoprol (1.8, 3.6 and 7.2 mg/kg), diminazene aceturate (3.5, 7 and 14 mg/kg), suramin (5, 10 and 20 mg/kg) and isometamidium (0.1, 1.0 and 2 mg/kg). A 13 isolates suspected to be resistant were selected for further testing in vitro and in vivo. From the in vitro testing, IC50 values were determined by short‐term viability assay, and MIC values were calculated by long‐term viability assay. For in vivo testing, doses higher than those in the initial screening test were used.Results  Two T. b rhodesiense stocks expressed resistance in vivo to melarsoprol at 5 mg/kg and at 10 mg/kg. These strains had high IC50 and MIC values consistent with those of the melarsoprol‐resistant reference strain. Another isolate relapsed after treatment with 5 mg/kg of melarsoprol although it did not appear resistant in vitro. One isolate was resistant to diminazene at 14 mg/kg and another was resistant at both 14 and 28 mg/kg of diminazene. These two isolates had high IC50 values consistent with the diminazene‐resistant reference strain. Two isolates relapsed at a dose of 5 mg/kg of suramin, although no isolate appeared resistant in the in vitro tests. Two isolates were resistant to isometamidium at 1.0 mg/kg and had higher IC50 values. Two isolates were cross‐resistant to melarsoprol and diminazene and one isolate was cross‐resistant to suramin and isometamidium.Conclusion  The reduced susceptibility of T. b. rhodesiense isolates to these drugs strongly indicates that drug resistance may be emerging in north–western Tanzania.

Từ khóa


Tài liệu tham khảo

10.1016/S0001-706X(00)00108-X

10.1016/S0304-4017(00)00427-1

10.1590/S0074-02761999000200018

10.1002/j.1460-2075.1985.tb03772.x

10.1016/S0169-4758(99)01414-3

10.1111/j.1550-7408.1981.tb05322.x

10.1046/j.1365-3156.2001.00775.x

Croft SL, 2004, WHO/TDR Scientific Working Group (SWG) Report on Leishmaniasis

10.2307/3281038

10.1016/S0001-706X(98)00002-3

Fairbairn H, 1948, Sleeping sickness in Tanganyika territory 1922–1946, Tropical Diseases Bulletin, 45, 1

Geerts S, 1998, Drug management and parasite resistance in Bovine Trypanosomiasis in Africa, 31

10.1016/0001-706X(93)90083-N

10.1128/AAC.41.9.1922

10.1016/0014-4894(89)90074-X

10.1128/AAC.33.6.881

10.1016/S0035-9203(99)90151-7

10.1016/S1286-4579(01)01432-0

10.1046/j.1365-3156.1997.d01-122.x

Mbwambo HA, 1988, Berenil (Diminazene aceturate) resistant Trypanosoma congolense in cattle under natural tsetse challenge at Kibaha, Tanzania, Acta Tropica, 45, 239

Nyeko JHP, 1988, Selection of drug resistance in T. congolense during cyclic transmissions through Glossina m.morsitans and drug treated rabbits, Acta Tropica, 45, 21

10.1016/0035-9203(61)90075-X

10.1016/0035-9203(94)90430-8

Perez Martin O, 1991, In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique 1985, Revista Cubana de Medicina Tropical, 43, 189

10.1038/167147a0

Sones KR, 1988, Assessment of sensitivity of T. Congolense to Isometamidium chloride: a comparison of tests using cattle and mice, Acta Tropica, 45, 153

Robertson DH, 1960, Increasing Mel B resistance in consecutively isolated strains of T. rhodesiense from a case of sleeping sickness refractory to treatment, EATRO Report, 1960, 35

Ruppol JF, 1977, Follow‐up des traitements contre la trypanosomiase experimentes a Kimpangu (Republic du Zaire), Annales de la Societe Belge de Medecine Tropicale, 57, 481

10.1007/978-2-8178-0857-4_15

10.1007/BF00931271